期刊
EMBO JOURNAL
卷 30, 期 12, 页码 2388-2404出版社
WILEY
DOI: 10.1038/emboj.2011.140
关键词
B-cell development; chromatin-modifying enzymes; epigenetic regulation; in vivo biotinylation; Pax5 target genes
资金
- Boehringer Ingelheim
- Austrian GEN-AU initiative by the Bundesminsterium fur Bildung und Wissenschaft
- European Union
- EMBO fellowship
Pax5 is a critical regulator of B-cell commitment. Here, we identified direct Pax5 target genes by streptavidin-mediated ChIP-chip analysis of pro-B cells expressing in vivo biotinylated Pax5. By binding to promoters and enhancers, Pax5 directly regulates the expression of multiple transcription factor, cell surface receptor and signal transducer genes. One of the newly identified enhancers was shown by transgenic analysis to confer Pax5-dependent B-cell-specific activity to the Nedd9 gene controlling B-cell trafficking. Profiling of histone modifications in Pax5-deficient and wild-type pro-B cells demonstrated that Pax5 induces active chromatin at activated target genes, while eliminating active chromatin at repressed genes in committed pro-B cells. Pax5 rapidly induces these chromatin and transcription changes by recruiting chromatin-remodelling, histone-modifying and basal transcription factor complexes to its target genes. These data provide novel insight into the regulatory network and epigenetic regulation, by which Pax5 controls B-cell commitment. The EMBO Journal (2011) 30, 2388-2404. doi: 10.1038/emboj.2011.140; Published online 6 May 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据